Clinical Report: Impact of Spatially Fractionated Radiation Therapy on Symptom Management

Overview

This retrospective cohort study evaluated the effects of Spatially Fractionated Radiation Therapy (SFRT) on symptom control and survival in patients with advanced bulky tumors. Results indicated symptomatic improvement in 55 of 60 patients and tumor regression in 45 of 51 patients, with manageable adverse events.

Background

Bulky tumors present significant challenges in oncology due to their size and complex microenvironments, which often lead to treatment resistance. Traditional therapies may be less effective, necessitating innovative approaches like SFRT. This technique aims to enhance tumor destruction while minimizing damage to surrounding healthy tissue, making it a critical area of research.

Data Highlights

Key Findings

• 91.7% of patients experienced symptomatic improvement following SFRT.
• 45 out of 51 patients with evaluable imaging showed tumor regression.
• The overall response rate (ORR) was 33.3%, with a disease control rate (DCR) of 96.1%.
• Median overall survival (OS) was recorded at 7.6 months.
• A BED-Vertex of ≥ 88 Gy was significantly associated with treatment response (P = 0.020).
• No grade 3 or higher toxicities were reported, indicating manageable adverse events.

Clinical Implications

Clinicians should consider BED-Vertex as a potential predictor of treatment response when planning SFRT.

Conclusion

SFRT demonstrates effectiveness in managing bulky tumors with limited toxicity.

Related Resources & Content

1. Frontiers in Oncology, 2026 -- Bibliometric Analysis of Global Research Trends in Spatially Fractionated Radiotherapy
2. Frontiers in Oncology, 2026 -- Stereotactic centralized ablative radiation therapy: a framework for ultra-heterogeneous radiotherapy of bulky tumors
3. Journal of Neuro-Oncology -- Comparative Analysis of Three-Fraction and Five-Fraction Stereotactic Radiosurgery Outcomes for Resected Brain Metastases
4. Blood Cancer Journal -- Clinical Outcomes in Stage I–II Hodgkin Lymphoma Patients Undergoing Standardized Pre-Treatment Staging with PET/CT and Limited Radiation Therapy Following Chemotherapy
5. Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials - PubMed
6. Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges - PMC
7. Study Details | NCT06416007 | Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors | ClinicalTrials.gov
8. Overview and Recommendations for Prospective Multi-institutional Spatially Fractionated Radiation Therapy Clinical Trials - PubMed
9. Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges - PMC
10. Study Details | NCT06416007 | Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors | ClinicalTrials.gov